Literature DB >> 24174212

Novel supine thoracentesis bed enabling thoracentesis via the posterior axillary line.

Kwang Nam Jin1, Jeong Min Ko, Jisoon Kim, Myeong Im Ahn, Seok-Chan Kim, Dae Hee Han.   

Abstract

PURPOSE: This study describes on supine thoracentesis bed (STB), which helps thoracentesis of supine patient by enabling unlimited access to the posterolateral surface of a hemithorax.
MATERIALS AND METHODS: Records of 15 patients who had received US-guided supine thoracentesis on STB were reviewed. We investigated the lateral or posterolateral approaches selected by the operators. We reviewed pre-procedural CT scans (obtained within 1 day) to examine if the approach of the operators could be justified in terms of depth of effusion and overlying chest wall thickness.
RESULTS: The most common rationale for the use of the supine position was back or leg pain in 6 patients and hemi-or quadriplegia in 4. The operators chose the posterolateral approach in all 15 patients. On 6 concurrent CT scans, the mean depth of effusion was significantly (p < 0.004) greater in the posterolateral approach (3.0 ± 2.2 vs. 1.5 ± 1.9 cm). There was no significant difference in the thickness of the chest wall between the two approaches (1.6 ± 0.3 vs. 1.8 ± 1.0 cm, p = 0.61).
CONCLUSIONS: By using STB, supine thoracentesis can be done via the posterolateral approach, which was associated with greater depth of effusion in our study, and may be superior to the conventional lateral approach.

Entities:  

Mesh:

Year:  2013        PMID: 24174212     DOI: 10.1007/s00270-013-0763-3

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  1 in total

1.  Depth of Pleural Effusion in Thoracentesis: Comparison of Lateral, Posterolateral and Posterior Approaches in the Supine Position.

Authors:  Jeong Min Ko; Jisoon Kim; Soo-An Park; Kwang Nam Jin; Myeong Im Ahn; Seok-Chan Kim; Dae Hee Han
Journal:  Iran J Radiol       Date:  2016-03-12       Impact factor: 0.212

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.